Chromogenics AB – turnaround company from Sweden?

I’ve been following the Swedish company Chromogenics for about four years and thought I’d open a thread about the company here, as I personally see a turnaround coming. The following text is based on my own experiences and memories of the company’s history, and I don’t guarantee that all facts are 100% accurate. I’ve also accumulated some shares in my portfolio and am eagerly awaiting what’s next.

General

The company’s roots trace back to research at Uppsala University in 2003, which studied the behavior of electrochromic materials. After 16 years of development, a product named ConverLight was launched on the market. The product is an intelligent glass film that automatically darkens a window in sunlight, thus preventing heat radiation from entering, without compromising the views from the window or the facade’s appearance, as curtains and window awnings currently do. In winter, when heat radiation is needed, the window does not prevent heat from entering. The glass can also be controlled remotely, for example, with a smartphone.

The product has a proven growing market and demand, especially in warm and sunny countries. I can only imagine how much the annual cooling costs are for a large, glass-paneled office skyscraper in sunny countries. With smart windows, property owners can achieve real savings in the long run.

Customers

The company’s current customers are large Nordic real estate companies, and products have been installed in several locations in Sweden and Norway, at least. School properties, commercial premises, and some private residential properties are among their references. The goal now is to get production up and running and scale globally through separate hubs.

The strategy is based on a roll-to-roll method, where the glass film is produced in Sweden and cost-effectively transported (compared to finished glass worldwide, damages, etc.) to hubs, where authorized glass shops then finish the window and deliver it to the construction site. This creates a significant scalability advantage over many competitors.

Competitors

There are other manufacturers of similar smart glass. View Inc. is the most well-known, with Softbank investing $1.1 billion a couple of years ago. Additionally, there’s SageGlass, for example, and more can be found by Googling. However, Chromogenics’ strategy of utilizing the aforementioned Roll-to-Roll process is significantly more cost-effective and scalable when the goal is growth.

Turnaround

Since the commercialization of the product, the company has traveled a long and rocky road. The company had a subcontractor who practically handled the entire manufacturing process of the product. The sales and marketing efforts in the early days of the product (2017-2019) were largely wasted during the first two years, as the products manufactured by the subcontractor repeatedly had significant quality and delivery problems. This meant that despite demand, the product could not be brought to market quickly and with sufficient quality, making sales difficult. The backlog from those quality issues is still being paid off.

In a difficult situation, the company decided to change its strategy in late 2019. The sensitive quality control of the product is paramount, and to keep it in check, the company must handle the manufacturing process from start to finish itself. To succeed in this, the company had to establish its own factory. A share issue was organized to raise money for production machines (Sputtering machines, 2 units), which, to my understanding, are perhaps, if not certainly, the only ones of their kind in Europe. The acquisition price for the machines was a total of €10M new, and they were purchased from a German bankruptcy estate. The condition of the deal was “both or nothing,” at a price of ~€5M. The intention is to change the production model so that the company itself produces glass film as a bulk product for several window manufacturers, thus achieving more efficient logistics globally.

Regarding machine capacity, it has been stated that the Sputter 1 machine has sufficient capacity to manufacture window film in very large volumes. The Sputter 2 machine is being tuned for other products, such as flexible printed circuit boards. The second machine enables entirely new areas of conquest by leveraging the company’s core expertise.

Below is a good article from last autumn regarding this turnaround! Google’s translated page in English:

Link to article: https://translate.google.com/translate?sl=sv\u0026tl=en\u0026u=https://etn.se/index.php/reportage/67298-egna-maskiner-ska-garantera-kvalitet.html

One idea is to make flexible printed circuit boards.

  • Imagine that you have a lot of conductors, maybe a meter long, which you replace with a flexible printed circuit board. For example, it can reduce cabling in cars or other types of products

Other ideas are about making different types of materials for heaters in, for example, batteries, or co-materials for bactericidal surfaces in hospitals.

  • There are very many customers. The solar cell industry can be one, where we can make passivation layers in the form of oxide or similar, says Leif Ljungqvist, and states:
    - Right now we have an overcapacity. At the same time, there is a great demand, so I think we can also become an important player in that market for sputtered film for a long time.”

The machines arrived at the Uppsala factory premises in early 2020, and then this pandemic hit. Foreign installers were called home, and installation work was significantly delayed and complicated. The share price started to fall again. Now, in spring 2021, the company is in a situation where the final quality tests of the manufacturing process are underway, and confirmations of production readiness are expected around April-May. This information is based on the company’s latest interim report.

The proximity of production readiness is also reinforced by a Norwegian institution placing a €2.3M order for window film in early March. Immediately after the order, a Swedish construction and window company made a buy/share exchange offer for CG’s share capital, which the CG board recommended rejecting. Information on this can be found on the company’s website and in press releases. This indicates that management has confidence in the project’s success.

In summary, it can be stated that the company has been paying for the lessons learned from subcontracting and the importance of quality control for almost 2.5 years now. In my opinion, we are now close to production readiness, and based on the CEO’s statements and the latest reports, there seems to be considerable demand. There is still work to be done, but the direction is right. It is possible that setbacks will occur. In my opinion, these have already been priced into the company’s valuation; those who have owned for a long time likely already have gray hair and a frozen beard from the descent… The image below shows the history:

I recommend watching a fairly recent video from the latest funding round. The language is Swedish, but even if you don’t speak the language, the video has good slides on processes and business. A few other presentation videos can also be found on YouTube.

https://www.youtube.com/watch?v=xrqLV3_1s4c

Opinions and comments, please!

60 Likes

Interesting price development…

3 Likes

Here’s a noteworthy reference to a partner as well. I’m also in with a small batch, watching to see if this Via Dolorosa will finally end. After following for many years, there’s finally a good chance.

5 Likes

Is this really a less than 2 million euro boutique? It’s not exactly big in size.

I need to take a look, but how long will that 2.3 million euro order be spread over? It’s immediately larger than the entire revenue of last (corona) year and more than half of the entire 2019 revenue.

There is certainly room for growth if things start to roll. I think I’ll watch from the sidelines with the idea that something so small and little followed is unlikely to immediately skyrocket, if we get some realized numbers from a successful turnaround. In such a situation, one could better assess the situation and happily join in even at a slightly higher price.

3 Likes

I jumped on board a few years ago and almost stopped following it, as the position is so much in the red, but now it looks better.
A good strategy would probably be to watch it for a bit now and jump in later if it starts to rise. I don’t want to try to lower the average price anymore; I’ll just wait for a potential bigger rise.

2 Likes

Interesting case. I saw a notice about this in the buy/sell thread a month ago and at that time I looked into the company’s operations a bit, and it seemed quite good at first glance.

Now, however, after reading through the local forum with the help of Google Translate, it seems there’s not too much trust in the company. Apparently, the entire management is too academic, lacks business acumen, and it’s all just dabbling. There was a lot of everything, but primarily negative. Worth checking out:

1 Like

I’ve also been following the Avanza forum for a while now, and the frustration that long-term owners surely feel emanates from it. An understandable reaction when the position is 80% in the red :slight_smile:

Let the products speak for themselves, and business seems to be going well… It’s better that they refine their processes properly without rushing, even though there’s certainly time pressure and the bottom of the cash register is showing… :+1:

3 Likes

It looked interesting, and the fact that the subcontracting error has already been corrected and their own factory is up and running is a plus, but the stock price also tells its own story - a real A-class falling knife so far… In addition, I’m a bit worried about the basic fact that the previous “news story” on their website is from June 2020, hyping a future product in cooperation with Samsung, but 9 months later there’s been no similar news story about it being completed.

Even in press releases, there’s only that one order from a month ago and so-called technical announcements (quarterly reports and that takeover stock swap thing).

A potentially bigger rally is certainly possible if things start to happen, but it’s difficult to assess the probability of this…

3 Likes

At least there’s more upside than downside, 200kr would be enough for me already :face_with_hand_over_mouth: I also browsed the Avanza discussions through a translator. There were indeed many comments about overly academic key personnel, but IF the product’s valuation was initially so high and the dip was due to quality issues that could be fixed with their own production, I see this as very interesting. I personally can’t grasp the impact of these equipment acquisitions versus in-house expertise on quality management. Does anyone who has followed this longer have information on this?

Edit. Is there any information about the price range of the tender offer from early March?

1 Like

Taking production in-house was something the management saw as essential when the strategy was changed. Only by keeping process and quality control in their own hands can sufficient quality be guaranteed. I remember this being emphasized on several occasions, and if you browse the 2019 quarterly reports, you’ll find information there.

2 Likes

The offer wasn’t anything special; as I understand it, it proposed a merger with a larger industry group, thereby gaining access to bigger sales channels. The actual premium was small compared to the current market cap, about 12%. The board advised rejecting the offer, so they probably have more confidence in their own work.

3 Likes

Interesting company, definitely need to research more.

I looked into smart windows a bit with View Inc., but I never invested in View. There were too many competitors and the valuation was too high. There are indeed several competitors, and a quick Google search reveals many interesting companies. It’s quite difficult for a novice to say which one is the best and why Chromogenics would succeed against them in the long run.

Are there any newer forecasts for revenue development or similar? I couldn’t find anything more recent than the IPO.

https://www.chromogenics.com/content/uploads/2018/06/chromogenics-emissionsteaser.pdf
https://www.chromogenics.com/content/uploads/2018/06/chromogenics-prospekt-feb2017.pdf

2 Likes

They have forecast future figures very little; I don’t remember seeing any charts recently. However, one significant thing comes to mind regarding growth prospects. Until now, the focus has only been on window films and their potential. The Sputter 1 machine has been reserved for this purpose. However, the Sputter 2 machine is also in the installation phase, and the Q4/2020 report contained a quite encouraging sentence about it:

“The installation of Sputter II is progressing parallel to the adjustment of the processes, and installation is estimated to be completed in H1 2021. The sale of the overcapacity in Sputter II has begun and discussions are being held with around 35 potential customers”

This opens up the game to a completely new market, and at least for me, the opportunity and scope it brings are currently unknown. Hopefully, more information on this will be available soon; at least, things are happening in the background with 35 potential customers.

The Q4/2020 report also mentioned that the quality tests for the Sputter 1 machine are nearing completion and will last 90 days. Some results will be available after 60 days. The report was published on February 19, 2021, so 3 months from then means that by the end of May, there could be some information about the start of production if all goes well. Let’s hope it does!

The company is now implementing the final adjustments to the nickel oxide process. Once the process has been established, tungsten oxide and nickel oxide will be produced in order to be able to conduct the final sustainability tests before ConverLight®Dynamic is once again released on the market. The tests that will be conducted are extensive and will be run for a period of 90 days. While the tests are ongoing, the company can regularly evaluate the product and assess its sustainability. The product’s quality will already become apparent after around 60 days.

Source: Q4/2020 report:
https://www.chromogenics.com/content/uploads/2021/02/chromogenics-q4-2020-eng.pdf

4 Likes

An interesting case indeed, and it certainly has potential if the turnaround can truly be executed and the new production machines get rolling.

Regarding the previous rejected takeover bid, commercialization, and internationalization, the company’s assessment is that TopRight would not have had the capacity to advance the business sufficiently. A new share issue is coming, based on comments. Many interested parties probably already know this, but it hasn’t been brought up in the thread.

https://www.chromogenics.com/press-and-news/the-board-of-chromogenics-advises-against-topright-nordics-takeover-bid/

"It is the Board’s assessment that commercialization and international expansion requires working capital that may – to a significant extent – need to be met through a new issue of shares. The Board assesses that neither TopRight as a possible principal owner nor TopRights’ principal owners has the necessary financial resources to be able to meet ChromoGenics’ external working capital needs in their capacity as shareholders in ChromoGenics. "

2 Likes

Okay, so if you want to buy into this, you can wait for the next offering, which will dilute old shareholders again and increase frustration.

4 Likes

This is how it is, my interest in buying ended at this point. Of course, it depends on the pricing of the offering or other possible financing arrangements, but looking at history, a value-raising offering is unlikely.

The timing is also essential; if, for example, the machines start singing and sales are made to the local market first, the valuation can quickly increase. After this, it would be more optimal to seek capital for internationalization, once there is evidence of production operations and market interest.

Some kind of merger with a larger player is, of course, also possible, if the offered valuation meets the owners’ view. So much money has been poured into the company over the years that the acceptable price tag might be quite high :sweat_smile:

Glaston, for example, could be a perfect match to create added value :rofl: [sarcasm]

1 Like

I found this news article.

“The offer to shareholders means that each ChromoGenics shareholder is offered one TopRight share for every 0.74 ChromoGenics shares.
TopRight also offers holders of TO3 series warrants one TopRight share for every 1.94 TO3 series options in ChromoGenics.
The estimated offer value for each ChromoGenics share is SEK 12 and for each TO3 series option, approximately SEK 4.58.
However, the offer will only be implemented if TopRight becomes the owner of shares corresponding to more than 60 percent of the total number of shares in ChromoGenics.”

1 Like

I’ve been thinking the same thing. The world is unlikely to be conquered before the basics are in order—machines are running and kronor are demonstrably flowing into the cash register from these Nordic orders. Then there will be concrete growth prospects, a higher valuation will be justified, and financiers will become interested. The atmosphere is anticipatory and trading volume is very small…

1 Like

Yeah, I actually invested in this with the exact same view as I did with Tecnotree back when they announced they weren’t filing for bankruptcy. So, the company has been beaten down as low as it can practically go. I think now could be the moment for a turnaround. So, if there’s any positive news, etc., the percentages will rise quickly. Holding requires guts, but personally, I don’t see much downside risk anymore. But in reality, there’s a lot of risk, and that’s why you have to invest amounts that won’t cost you sleep. With this stock, probably the smartest way is to wait for the price/news to give a clear signal upwards! :victory_hand::beer_mug:

9 Likes

I quickly read through the latest quarterly report. In this case, please also note the risk that, as far as I know, it is not yet even known how good a quality this first machine brought into the company’s operation will produce. What guarantees are there that quality problems in the films and process will not continue? The machine’s quality tests are now underway. It’s a bit of a gamble here, because if the results are not positive, a new, proper deep dive will likely be encountered, due to a delay of approximately 6-12 months? The quality test alone takes 90 days, plus the necessary technical modifications and production trials.

It’s positive that orders have also come in, but is a small Swedish company a winner in this market, when it’s up against players with really deep pockets? I think the dilution goblin is also something to worry about in this case.

11 Likes